ARIAD Pharmaceuticals
| Use attributes for filter ! | |
| Ceo | Paris Panayiotopoulos |
|---|---|
| Revenue | 118. 8 million USD (2015) |
| Headquarters | Cambridge |
| Massachusetts | |
| United States | |
| Number of employees | 380 (2016) |
| Subsidiaries | ARIAD Corporation |
| ARIAD Gene Therapeutics, Inc | |
| Parent organizations | Takeda Pharmaceuticals U. S. A. , Inc. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844711 |
About ARIAD Pharmaceuticals
ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M. D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients.
